Advanced Liver Transplant & Hepatology Care
For International & NRI Families
Dr Chetan Kalal | Mumbai, India
When liver disease becomes complex, unstable, or transplant-relevant, families require structured medical leadership — not fragmented opinions.
Dr Chetan Kalal provides high-acuity hepatology and transplant medicine for international patients seeking advanced evaluation, second opinion, or definitive transplant pathway planning in India.
This is not medical tourism.
This is clinically directed transplant strategy.
Who This Is For
This pathway is designed for:
NRI families evaluating India for liver transplant
Patients with rising MELD scores
Recurrent decompensation (ascites, variceal bleed, encephalopathy)
Acute-on-chronic liver failure
Complex autoimmune or Wilson disease
Borderline transplant eligibility cases
Patients denied listing seeking structured reassessment
If the decision impacts survival within 6–12 months, clarity is essential.
Structured International Pathway
Step 1: Pre-Arrival Clinical Review
Before travel:
• Complete medical record submission
• Lab & imaging review
• Transplant eligibility screening
• Risk stratification
• Defined recommendation (medical optimization vs transplant evaluation)
You receive written documentation before committing to travel.
Step 2: India Arrival – Coordinated Evaluation
Upon arrival:
• Parallel donor-recipient assessment (for living donor cases)
• Multidisciplinary transplant board review
• ICU risk assessment
• Financial transparency discussion
• Timeline projection
No informal shortcuts.
Every case follows protocol.
Step 3: Surgical & ICU Coordination
For transplant candidates:
• Pre-operative optimization
• Organ failure stabilization
• Infection risk control
• ICU oversight
• Post-operative graft monitoring
Families are updated with structured clinical summaries — not vague reassurances.
Step 4: Global Aftercare Strategy
After discharge:
• Immunosuppression planning
• Remote lab monitoring framework
• International physician coordination
• Long-term graft surveillance protocol
Continuity matters more than surgery alone.
Clinical Domains of Expertise
Advanced Chronic Liver Disease
Living Donor Liver Transplant
Acute-on-Chronic Liver Failure
Autoimmune Hepatitis & Overlap Syndromes
Wilson Disease
MASLD / NASH with Advanced Fibrosis
Transplant Re-evaluation & Second Opinion
What International Families Value
✔ Direct consultant-level access
✔ Structured documentation
✔ Defined transplant timing
✔ Ethical eligibility assessment
✔ Transparent decision-making
✔ Controlled hospital coordination
✔ Clear cost discussions
This pathway is designed for families who prioritize clinical precision over marketing narratives.
Why India for Transplant Evaluation?
India offers:
High-volume living donor expertise
Shorter waiting timelines
Structured multidisciplinary programs
Cost predictability compared to US/UK systems
However, transplant should be medically justified — not financially motivated.
That distinction matters.
Direct Second Opinion for International Patients
For families unsure about transplant timing:
A structured second opinion includes:
• MELD & risk recalculation
• Survival projection
• Medical optimization strategy
• Clear transplant window advice
• Written summary suitable for local physicians
You should not travel without clarity.
Geographic Reach
Patients consult from:
United States
United Kingdom
UAE (Dubai / Abu Dhabi)
Singapore
Australia
New Zealand
Canada
Middle East
Europe
Virtual consults are available prior to travel planning.
Discretion & Confidentiality
High-profile or high-net-worth patients may request:
• Discreet scheduling
• Controlled visitor access
• Limited public disclosure
• Structured communication hierarchy
Medical privacy is respected.
Appointment & International Coordination
Website: drchetankalal.com
Consult Pathways:
International Virtual Hepatology Consult
Structured Transplant Second Opinion
NRI India Transplant Evaluation
Post-Transplant Global Follow-Up
Dedicated international coordination support available upon request.
